Ovarian cancer--progress and stagnation
Menczer, J.
Harefuah 118(3): 161-164
1990
ISSN/ISBN: 0017-7768 PMID: 2187770 Document Number: 350825
Document emailed within 1 workday
Related Documents
Delépine, N.; Alkallaf, S.; Cornille, Hélène.; Markowska, B.; Delépine, Gérard. 2003: Progress and stagnation in chemotherapy protocols for primary osteosarcoma Annales de Medecine Interne 154(1): 12-24Válek, A. 1987: Regular dialysis therapy in the 80s of the 20th century--progress or stagnation? Vnitrni Lekarstvi 33(8): 713-721
Vlassoff, C. 1991: Progress and stagnation: changes in fertility and women's position in an Indian village Population Studies 46(2): 195-212
Young, R.C. 1984: Ovarian cancer treatment: progress or paralysis? Seminars in Oncology 11(3): 327-329
Capen, C.V.; Magrina, J.F.; Masterson, B.J. 1982: Ovarian cancer: recent progress in surgery and chemotherapy Journal of the Kansas Medical Society 83(3): 128-129; 151
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Gitsch, E.; Salzer, H. 1993: Progress in the management of ovarian cancer at the First Department of Obstetrics and Gynecology, University of Vienna, since 1955 Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 55(2): 145-149
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Thumerelle, P. 1994: Une population écartelée entre explosion et stagnation, jeunesse et vieillissement (Population torn between explosion and stagnation, between youth and ageing) Bulletin de l'Association de géographes français 71(5): 486-494
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Chou, Y-Ching.; Chen, Y-Jen.; Lai, C-Ru.; Wang, P-Hui.; Hsin-Chan; Yuan, C-Chung. 2006: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis European Journal of Obstetrics Gynecology and Reproductive Biology 124(1): 101-105
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716
Rohde, E.; Reincke, I.; Barten, M. 1986: Ovarian metastasis of cancer of the small intestine with simultaneous ovarian pregnancy Zentralblatt für Gynakologie 108(19): 1184-1188
Ishii, K.; Aoki, Y.; Takakuwa, K.; Tanaka, K. 2001: Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer Journal of Reproductive Medicine 46(4): 347-352
Peng, P.; Shen, J. 2004: Progress on the study of ovarian carcinoma vaccine Zhonghua Fu Chan Ke Za Zhi 39(7): 500-502